Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-03-30

FDA Approved: SODIUM POLYSTYRENE SULFONATE — Original Application (KVK-Tech, Inc.)

View source ↗

Summary

FDA approved the original application for sodium polystyrene sulfonate from KVK-Tech, Inc., enabling a generic product for treating hyperkalemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium polystyrene sulfonate (Sodium polystyrene sulfonate)

Snippet

ORIG AP for SODIUM POLYSTYRENE SULFONATE (SODIUM POLYSTYRENE SULFONATE)